Although I recently suggested that Wall Street has already amply rewarded Procter & Gamble (NYSE:PG) for its self-improvement potential, the company showed in its fiscal second quarter results that it may still have more on the table. While incrementally less momentum in developing economies could eventually develop into another problem to address, P&G management is simultaneously delivering on product innovation/introduction and cost cutting.

SEE: A Guide To Investing In Consumer Staples

Good Results from the Top on Down
P&G posted a good, solid beat for its fiscal second quarter. Revenue rose 2% as reported, but increased 3% on an organic basis (about 1% higher than expected), with even progress in both volume and price. Good results in developed markets are counterbalancing slowing growth in developing markets.

Growth was relatively consistent across product lines, even if the make-up of that growth was not. Grooming saw 2% organic growth (on zero volume growth), while beauty and fabric/home care were both up 3% (on zero and 2% volume growth, respectively). Health care was up 4% (on 3% volume growth), while baby/family care revenue rose 5% on 6% growth in volume.

Cost-cutting and margin improvement are key to the P&G story now, and management continues to deliver good results. Core gross margin improved more than a point, while core/adjusted operating income rose 7% (with no incremental operating margin improvement net of the gross margin improvement). Here, too, the categories were across the board - beauty, fabric/home and baby/family all posted low-to-mid teens segment profit growth, while grooming was flat and health care was down in the mid-to-high single digits.

Although below-the-line items did boost P&G's reported results, the company still posted a clean beat of five or six cents on better sales and margins.

SEE: Make Money With The Consumer Cyclical And Staple Indicator

Relative Performance Seems to Put P&G in the Middle
While better-than-expected performance is almost always a positive, it's also true that doing a little bit better means less if your peers are all doing a lot better. To that end, Procter & Gamble's performance seems to fit in the middle of the pack.

Unilever (NYSE:UL) saw nearly 8% organic growth, with nearly 5% growth in volume. Kimberly-Clark (NYSE:KMB) was also quite strong with 5% organic growth for its December quarter. On the other hand, Helen Of Troy (Nasdaq:HELE) saw a revenue decline in its personal care segment for the quarter that ended November 30. Johnson & Johnson (NYSE:JNJ) saw just 1% operational growth in its consumer segment, with categories like baby care (up 3%) and oral care (up 2%) showing comparable-to-lower performance relative to P&G.

All in all, however, I'm not too worried about where P&G sits in the industry. The company's portfolio tends to skew toward the higher end of the price range, which may explain why the company saw year-on-year share loss but improving sequential results. In other words, I think consumers are starting to feel a little better about their budgets/economic situations and tentatively going back up market - at least on selective items.

SEE: 5 Must-Have Metrics For Value Investors

The Bottom Line
The next couple of quarters will be important for Procter & Gamble on at least two levels. The Street will want more proof that the cost/margin improvements are real and sustainable. More importantly, the company also has several product launches coming up, and seeing good acceptance/sales of these products will definitely help sentiment and bulwark the near-term revenue outlook.

With P&G's modest outperformance, I'm modestly taking my numbers/estimates a little higher. Ultimately, however, not a lot changes. While I believe P&G can grow revenue at a mid-single-digit rate and grow cash flow at a high-single-digit rate, a fair value in the low $70s still doesn't suggest any real undervaluation in these shares today.

At the time of writing, Stephen D. Simpson did not own any shares in any company mentioned in this article.

Related Articles
  1. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  2. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  3. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  4. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  5. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  6. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  7. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
  8. Investing News

    A 2016 Outlook: What January 2009 Can Teach Us

    January 2009 and January 2016 were similar from an investment standpoint, but from a forward-looking perspective, they were very different.
  9. Mutual Funds & ETFs

    3 Vanguard Equity Fund Underperformers

    Discover three funds from Vanguard Group that consistently underperform their indexes. Learn how consistent most Vanguard low-fee funds are at matching their indexes.
  10. Investing News

    Alphabet Earnings Beat Expectations (GOOGL, AAPL)

    Alphabet's earnings crush analysts' expectations; now bigger than Apple?
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center